| Literature DB >> 34345607 |
Haru Setyo Anggani1, Putri Arifiani1, Erwin Siregar1.
Abstract
White spots are common side effects of orthodontic treatment, and their presence after debonding appears unesthetic. This study aimed to quantify and compare the visual improvement in postdebonding white spot lesions following fluoride and casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) application. The sample included 42 upper premolars extracted for orthodontic reasons. Universal premolar brackets were bonded to the facial surfaces of the teeth that were exposed to a demineralization solution to create artificial white spot lesions, after which the brackets were debonded. The specimens were randomly allocated to three treatment groups (n = 14, each): acidulated phosphate fluoride (APF) gel application group; CPP-ACP paste application group; and control group. pH cycling was conducted to all groups for 14 days. Quantitative measurements were carried out using a spectrophotometer at the following times: before and after the white spot lesions artificially formed and after treating them. All groups showed significant differences in color change before and after treatment. However, there was no significant difference in the color improvement between the APF gel and CPP-ACP paste application groups. Although CPP-ACP application improved the color of the white spot lesions, it did not differ significantly from that of fluoride application. Copyright:Entities:
Keywords: Color improvement; casein phosphopeptide–amorphous calcium phosphate; fluoride; white spot
Year: 2021 PMID: 34345607 PMCID: PMC8300321 DOI: 10.4103/japtr.JAPTR_203_21
Source DB: PubMed Journal: J Adv Pharm Technol Res ISSN: 0976-2094
Figure 1White spot lesions seen clinically when debonding (Source: Sudjalim TR, 2006)[5]
Figure 2Illustration of the spectrophotometer used in research and industry (Konica Minolta CM-2600d) (Source: http://www.quiminet.com)
Figure 3Bland–Altman plot for ΔEstart measurement. (ΔEstart, value obtained after the white spot was artificially formed)
Figure 4Bland–Altman plot for ΔEend measurement. (ΔEend, value obtained after the white spot was treated for 14 days)
Descriptive test results
| Group | Value obtained | Color change (unit), mean±SD | Normality test, Shapiro-Wilk ( | |
|---|---|---|---|---|
| Fluoride application | 14 | ΔEstart* | 11.015±1.976 | 0.943 (>−0.05) |
| ΔEend† | 7.358±1.992 | 0.624 (>0.05) | ||
| CPP-ACP application | 14 | ΔEstart | 10.259±2.748 | 0.044 (<−0.05)§ |
| ΔEend | 5.462±2.749 | 0.134 (>−0.05) | ||
| Control | 14 | ΔEstart | 10.348±4.050 | 0.333 (>−0.05) |
| ΔEend | 9.196 ± 3.945 | 0.060 (>−0.05) |
*Value obtained after the white spot was artificially formed, †Value obtained after the white spot was treated for 14 days, §P<0.05, data distribution was not normal. CPP-ACP: Casein phosphopeptide-amorphous calcium phosphate, SD: Standard deviation
Wilcoxon test results for white spot color change before and after fluoride application
| Group | Value obtained | Median (minimum-maximum) | ||
|---|---|---|---|---|
| Fluoride application | 14 | ΔEstart | 10.94 (7.04-14.28) | 0.001 |
| ΔEend* | 7.19 (2.58-10.53) |
*Value obtained after the white spot was treated for 14 days
Wilcoxon test results for white spot color change in the control group
| Group | Value obtained | Median (minimum-maximum) | ||
|---|---|---|---|---|
| Control | 14 | ΔEstart* | 9.68 (4.82-18.60) | 0.001 |
| ΔEend† | 8.36 (4.58-17.74) |
*Value obtained after the white spot was artificially formed, †Value obtained after the white spot was treated for 14 days
Comparison of white spot color changes after treatment in acidulated phosphate fluoride application, casein phosphopeptide-amorphous calcium phosphate application, and control groups
| Group | Median (minimum-maximum) | ||
|---|---|---|---|
| Fluoride application | 14 | 3.18 (1.19-10.18) | <0.001 |
| CPP-ACP† application | 14 | 4.23 (2.55-8.23) | |
| Control | 14 | 0.96 (0.19-2.52) |
*Kruskal-Wallis test, †P<0.001 post hoc MannWhitney U-test: Fluoride application group versus CPP-ACP application group, P=0.05; Fluoride application group versus control group, P<0.001; CPP-ACP application group versus control group, P<0.001. CPP-ACP: Casein phosphopeptide-amorphous calcium phosphate
Wilcoxon test results for white spot color change before and after casein phosphopeptideamorphous calcium phosphate application
| Group | Value obtained | Median (minimum-maximum) | ||
|---|---|---|---|---|
| CPP-ACP* application | 14 | ΔEstart† | 9.37 (7.31-16.55) | 0.001 |
| ΔEend‡ | 4.61 (2.16-11.17) |
*P<0.00. †Value obtained after the white spot was artificially formed, ‡Value obtained after the white spot was treated for 14 days. CPP-ACP: Casein phosphopeptideamorphous calcium phosphate